Activation of mu-opioid receptors are required for the conditioned enhancement of NK cell activity

被引:20
作者
Hsueh, CM [1 ]
Chen, SF [1 ]
Huang, HJ [1 ]
Ghanta, VK [1 ]
Hiramoto, RN [1 ]
机构
[1] UNIV ALABAMA, DEPT BIOL & MICROBIOL, BIRMINGHAM, AL 35294 USA
关键词
opioid receptor antagonist; cyprodime hydrobromide (cyprodime HBr); ICI-174864; nor-binaltorphimine dihydrochloride (nor-BNI); NK cell activity; conditioning;
D O I
10.1016/0006-8993(96)00740-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The type of opioid receptors involved in the conditioned enhancement of natural killer (NK) cell activity is identified in the present study. In our previous observations, we have demonstrated that the conditioned enhancement of NK cell activity was dependent on beta-endorphin and methionine-enkephalin, but not dynorphin. Based on the interaction of opioids with their homologous receptors, we concluded that mu- and delta-opioid receptors might be involved. To further classify the type(s) of opioid receptors involved in eliciting the conditioned NK cell activity, three opioid receptor antagonists, cyprodime hydrobromide, ICI-174864, and nor-binaltorphimine dihydrochloride, were used to block the conditioned NK cell activity in BALB/c mice. Blocking was conducted by intracisternal injection of the drugs. The results showed that the activation of mu-opioid receptors was required in the conditioned enhancement of NK cell activity, but not the delta- or kappa-type of receptors.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 38 条
[1]   IS CONTIGUITY DETECTION IN CLASSICAL-CONDITIONING A SYSTEM OR A CELLULAR PROPERTY - LEARNING IN APLYSIA SUGGESTS A POSSIBLE MOLECULAR SITE [J].
ABRAMS, TW ;
KANDEL, ER .
TRENDS IN NEUROSCIENCES, 1988, 11 (04) :128-135
[2]   CNS - IMMUNE-SYSTEM INTERACTIONS - CONDITIONING PHENOMENA [J].
ADER, R ;
COHEN, N .
BEHAVIORAL AND BRAIN SCIENCES, 1985, 8 (03) :379-395
[3]   HYPOTHALAMIC OPIOID PEPTIDE REGULATION OF CATECHOLAMINE SECRETION [J].
APPEL, NM ;
KIRITSYROY, JA ;
VANLOON, GR .
NEUROPEPTIDES, 1984, 5 (1-3) :287-290
[4]   AUTONOMIC AND ENDOCRINE PARTICIPATION IN OPIOID PEPTIDE-INDUCED HYPERGLYCEMIA [J].
APPEL, NM ;
TRACK, NS ;
VANLOON, GR .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1987, 20 (03) :221-231
[5]  
BLALOCK JE, 1985, FED PROC, V44, P108
[6]   INTERRELATIONSHIPS OF OPIOIDERGIC AND ADRENERGIC-MECHANISMS CONTROLLING THE SECRETION OF CORTICOTROPIN RELEASING-FACTOR IN THE RAT [J].
BUCKINGHAM, JC ;
COOPER, TA .
NEUROENDOCRINOLOGY, 1987, 46 (03) :199-206
[7]   THE MUSCARINIC CHOLINERGIC AGONIST ARECOLINE STIMULATES THE RAT HYPOTHALAMIC-PITUITARY-ADRENAL AXIS THROUGH A CENTRALLY-MEDIATED CORTICOTROPIN-RELEASING HORMONE-DEPENDENT MECHANISM [J].
CALOGERO, AE ;
KAMILARIS, TC ;
GOMEZ, MT ;
JOHNSON, EO ;
TARTAGLIA, ME ;
GOLD, PW ;
CHROUSOS, GP .
ENDOCRINOLOGY, 1989, 125 (05) :2445-2453
[8]   EFFECTS OF THE SELECTIVE KAPPA OPIOID ANTAGONIST, NOR-BINALTORPHIMINE, ON ELECTRICALLY-ELICITED FEEDING IN THE RAT [J].
CARR, KD ;
BAK, TH ;
SIMON, EJ ;
PORTOGHESE, PS .
LIFE SCIENCES, 1989, 45 (19) :1787-1792
[9]   ARECOLINE A MUSCARINIC CHOLINERGIC AGENT CONDITIONS CENTRAL PATHWAYS THAT MODULATE NATURAL-KILLER-CELL ACTIVITY [J].
DEMISSIE, S ;
ROGERS, CF ;
HIRAMOTO, NS ;
GHANTA, VK ;
HIRAMOTO, RN .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 59 (1-2) :57-63
[10]   THE ROLE OF OPIOID-PEPTIDES IN IMMUNOMODULATION [J].
GILMORE, W ;
MOLONEY, M ;
WEINER, LP .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 597 :252-263